# Biomat USA Inc – FDA Inspection, Nov 6, 2025

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/46e88c78-4352-47cb-8151-b8b8775f6a1d
Source feed: FDA_Inspections

> FDA inspection 1289250 of Biomat USA Inc, November 06, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1289250
- Company Name: Biomat USA Inc
- Inspection Date: 2025-11-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1293838 - 2026-09-04
- FDA Inspection 1194611 - 2023-01-05

## Related Officers

- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/biomat-usa-inc/6b275f7a-a5af-4c01-8b51-0f022826ccc5

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
